Colorado enrolls first patient in clinical trial of HDAC inhibitor, OKI-179

IMAGE: This is Jennifer Diamond, MD, primary investigator of OKI-179 clinical trial. view more  Credit: University of Colorado Cancer Center OnKure, Inc. and the University of Colorado Cancer Center today announced enrollment of the first patient in a first-in-human phase 1 clinical trial testing investigational anti-cancer agent OKI-179, a novel and Class-selective HDAC inhibitor, in patients…

Details

Biting backfire: Some mosquitoes actually benefit from pesticide application

IMAGE: This is a predatory damselfly from the bromeliads. view more  Credit: Jennifer Weathered/Utah State University The common perception that pesticides reduce or eliminate target insect species may not always hold. Jennifer Weathered and Edd Hammill report that the impacts of agricultural pesticides on assemblages of aquatic insects varied resulting in distinct ecological winners and losers…

Details